Variant report
Variant | nsv521665 |
---|---|
Chromosome Location | chr6:133627248-133628237 |
allele | n/a |
Outlinks | Ensembl   UCSC |
- TF binding region (count:0)
- CpG islands (count:0)
- Chromatin interactive region (count:0)
- LncRNA region (count:0)
- Mature miRNA region (count: 0)
- miRNA target sites (count:0)
No data |
No data |
No data |
No data |
No data |
No data |
No data |

No. | Variant name | Chromosome position | Chromatin state | Related regulatory elements | Target genes | Extended variants | Associated traits |
---|---|---|---|---|---|---|---|
1 | rs2027210 | chr6:133627248-133627249 | Weak transcription Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | mRNA abundance |
2 | rs62430317 | chr6:133627269-133627270 | Weak transcription Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
3 | rs181339372 | chr6:133627287-133627288 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
4 | rs550370680 | chr6:133627292-133627293 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
5 | rs567076171 | chr6:133627315-133627316 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
6 | rs374894666 | chr6:133627322-133627323 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
7 | rs533897971 | chr6:133627334-133627335 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
8 | rs547113483 | chr6:133627335-133627336 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
9 | rs566839347 | chr6:133627360-133627361 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
10 | rs186479094 | chr6:133627361-133627362 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
11 | rs556172423 | chr6:133627390-133627391 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
12 | rs62430318 | chr6:133627399-133627400 | Weak transcription Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
13 | rs567398285 | chr6:133627473-133627474 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
14 | rs537682590 | chr6:133627573-133627574 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
15 | rs74382814 | chr6:133627616-133627617 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
16 | rs17062316 | chr6:133627629-133627630 | Weak transcription Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
17 | rs189399542 | chr6:133627733-133627734 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
18 | rs575131424 | chr6:133627738-133627739 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
19 | rs376966633 | chr6:133627798-133627799 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
20 | rs201086572 | chr6:133627859-133627860 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
21 | rs555063716 | chr6:133627862-133627863 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
22 | rs571772304 | chr6:133627970-133627971 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
23 | rs540818510 | chr6:133628019-133628020 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
24 | rs35244487 | chr6:133628024-133628025 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
25 | rs553065496 | chr6:133628029-133628030 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
26 | rs145904058 | chr6:133628086-133628087 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
27 | rs540632854 | chr6:133628090-133628091 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
28 | rs545010236 | chr6:133628095-133628096 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
29 | rs564685610 | chr6:133628151-133628152 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
30 | rs536053538 | chr6:133628190-133628191 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
31 | rs374241346 | chr6:133628207-133628208 | ZNF genes & repeats Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
32 | rs199759409 | chr6:133628226-133628227 | ZNF genes & repeats Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
33 | rs17062322 | chr6:133628237-133628238 | ZNF genes & repeats Weak transcription Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
Disease | PMID | Source |
---|---|---|
Uveal melanoma | 21693616 | CNVD |
Glioblastoma multiforme | 21080181 | CNVD |
Biliary cancer | 19435499 | CNVD |
Medulloblastoma | 21979893 | CNVD |
Malaria | 21533027 | CNVD |
T-cell prolymphocytic leukemia | 19278963 | CNVD |
Ewing''s sarcoma | 17952124 | CNVD |
Autism | 21448237 | CNVD |
Autism | 22495311 | CNVD |
Biliary cancer | 20360734 | CNVD |
Breast cancer | 20360734 | CNVD |
Coronary artery disease | 20360734 | CNVD |
Crohn''s disease | 20360734 | CNVD |
Hypertension | 20360734 | CNVD |
Rheumatoid arthritis | 20360734 | CNVD |
Type 1 diabetes | 20360734 | CNVD |
Type 2 diabetes | 20360734 | CNVD |
Acute lymphoblastic leukemia | 22237106 | CNVD |
Neuroblastoma | 18923191 | CNVD |
Hodgkin''s lymphoma | 17606441 | CNVD |
Melanoma | 18172304 | CNVD |
Cancer | 21637783 | CNVD |
Colorectal cancer | 16272173 | CNVD |
Gastric cancer | 17908304 | CNVD |
lymphocytic leukemia | 21291569 | CNVD |
Acute lymphoblastic leukemia | 20435627 | CNVD |
Follicular lymphoma | 19010834 | CNVD |
Non-small cell lung cancer | 21044232 | CNVD |
Endometrial cancer | 22040021 | CNVD |
Breast cancer | 21264507 | CNVD |
Esophageal squamous carcinoma | 21637470 | CNVD |
Glioblastoma multiforme | 19960244 | CNVD |
Hepatocellular carcinoma | 22174799 | CNVD |
Phyllodes tumor | 17334353 | CNVD |
Breast cancer | 16608533 | CNVD |
Non-small cell lung cancer | 21385341 | CNVD |
Prostate cancer | 16705090 | CNVD |
Adenoid cystic carcinoma | 17372589 | CNVD |
Ependymoma | 16718352 | CNVD |
High-proliferative meningiomas | 17937814 | CNVD |
Intracranial tumor | 16823260 | CNVD |
Monoclonal gammopathy of undetermined significance | 17077331 | CNVD |
Basal cell lymphoma | 16317097 | CNVD |
Diffuse large b-cell lymphoma | 16317097 | CNVD |
Breast cancer | 16272173 | CNVD |
Prostate cancer | 18632612 | CNVD |
Wilms tumour | 21544195 | CNVD |
Acute lymphoblastic leukemia | 20067559 | CNVD |
Glioma | 21046410 | CNVD |
Primary central nervous system lymphoma | 21088137 | CNVD |
Zellweger syndrome | 21572526 | CNVD |
Follicular lymphoma | 20505157 | CNVD |
Congenital diaphragmatic hernia | 21085971 | CNVD |
Malignant melanoma | 18718029 | CNVD |
Lung adenocarcinoma | 21935476 | CNVD |
Invasive pancreatic ductal carcinoma | 16982739 | CNVD |
Acute lymphoblastic leukemia | 17690704 | CNVD |
Lung cancer | 18438408 | CNVD |
Breast cancer | 21858162 | CNVD |
Chronic lymphocytic leukemia | 21546498 | CNVD |
Breast cancer | 17603634 | CNVD |
Chondromyxoid Fibroma | 20696777 | CNVD |
Cancer | 21183584 | CNVD |
Developmental delay | 19490664 | CNVD |
Non-muscle invasive bladder neoplasm | 19445696 | CNVD |
Burkitt''s lymphoma | 18698080 | CNVD |
Breast cancer | 21785460 | CNVD |
Kartagener syndrome | 16639409 | CNVD |
Breast cancer | 17133270 | CNVD |
Follicular lymphoma | 18703704 | CNVD |
Neurodevelopmental disorder | 22521361 | CNVD |
small cell lung cancer | 20016488 | CNVD |
Adenoid cystic carcinoma | 18698036 | CNVD |
head and neck squamous cell carcinoma | 17671120 | CNVD |
Leukemia | 18688285 | CNVD |
Breast cancer | 21364760 | CNVD |
Myelofibrosis | 22110671 | CNVD |
Renal cell carcinoma | 18592004 | CNVD |
T-cell prolymphocytic leukemia | 17713554 | CNVD |
Non-syndromic sensorineural hearing loss | 17122850 | CNVD |
Non-syndromic sensorineural hearing loss | 18451855 | CNVD |
Cancer | 20164919 | CNVD |
Breast cancer | 22522925 | CNVD |
Pancreatic cancer | 17952125 | CNVD |
No. | Chromosome Location | Chromatin state | Cell line | Tissue |
---|---|---|---|---|
1 | chr6:133599000-133629000 | Weak transcription | Ganglion Eminence derived primary cultured neurospheres | brain |
2 | chr6:133613000-133630600 | Weak transcription | Cortex derived primary cultured neurospheres | brain |
3 | chr6:133613000-133655000 | Weak transcription | Hela-S3 | cervix |
4 | chr6:133623200-133636200 | Weak transcription | IMR90 fetal lung fibroblasts Cell Line | lung |
5 | chr6:133626200-133627400 | Enhancers | Psoas Muscle | Psoas |
6 | chr6:133627000-133627400 | Weak transcription | Skeletal Muscle Female | skeletal muscle |
7 | chr6:133627000-133633200 | Weak transcription | Skeletal Muscle Male | skeletal muscle |
8 | chr6:133627200-133628200 | Weak transcription | hESC Derived CD184+ Endoderm Cultured Cells | ES cell derived |
9 | chr6:133627400-133627600 | Enhancers | Skeletal Muscle Female | skeletal muscle |
10 | chr6:133627400-133628400 | Enhancers | Foreskin Melanocyte Primary Cells skin03 | Skin |
11 | chr6:133627400-133633200 | Weak transcription | Psoas Muscle | Psoas |
12 | chr6:133627600-133637000 | Weak transcription | Skeletal Muscle Female | skeletal muscle |
13 | chr6:133628000-133629000 | Enhancers | Mesenchymal Stem Cell Derived Chondrocyte Cultured Cells | embryonic stem cell |
14 | chr6:133628200-133628400 | Enhancers | Bone Marrow Derived Cultured Mesenchymal Stem Cells | Bone marrow |
15 | chr6:133628200-133628800 | Enhancers | Mesenchymal Stem Cell Derived Adipocyte Cultured Cells | ES cell derived |
16 | chr6:133628200-133629800 | ZNF genes & repeats | hESC Derived CD184+ Endoderm Cultured Cells | ES cell derived |